Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)

May 02, 2014, 10:30 ET from Bharat Book Bureau

MUMBAI, May 2, 2014 /PRNewswire/ --

Bharat Book Bureau presents Global & USA Cancer Biomarker Market to 2018. It is a comprehensive report on the cancer biomarker industry and its impact on the health system. This report tackles the growing market interest in oncogenic biomarkers, personalized medicine, companion diagnostics and the associated market environment.

Cancer biomarkers are molecular or genetic moieties (e.g., cells, proteins/peptides, genetic mutations, gene products, enzymes, or hormones) that not only are readily identifiable, but easily quantified in the lab setting. They function primarily to identify or correlate significantly with the severity or occurrence of a certain disease state. The rise in number of oncogenic biomarkers over the last number of years has massive potential in the healthcare industry and serves to propel both the personalized medicine and companion diagnostic markets.

One of the most import aspects of biomarkers is their use to diagnose and assess the progress of disease states in patients. As quantitative markers, these agents also offer the ability to monitor response to certain drug treatments and so are important in the area of personalized medicine.

Individualized, targeted or personalized medicine aims to increase the efficacy of therapeutics via genetic testing and companion diagnostics. Personalized therapeutics and associated companion diagnostics will be more specific and effective thereby giving pharma/biotech companies a significant advantage to recuperate R&D costs. Personalized medicine will reduce the frequency of adverse drug reactions and therefore have a dramatic impact on health economics. Developmental and diagnostic companies will benefit from lower discovery and commercialization costs and more specific market subtypes.

This report describes the current technologies that are propelling the cancer biomarker and companion diagnostic market. It examines the current genetic diagnostic tests and companion diagnostic assays that are in use by the medical and pharmaceutical industry today. Current developments in personalized medicine and the pharmacogenomic revolution are discussed. The emerging trends that appear in the global market and the most developed market (US) are elucidated and analyzed. This study reveals market figures of the overall biomarker market and the cancer biomarker space (2013-2018). Forecast projections and future growth rates are provided to give the reader a forthcoming perspective of this growing industry.

The study also provides a comprehensive financial, business strategy and product review of key players in the cancer biomarker industry. Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.

In summary, the cancer biomarker and associated companion diagnostic market have huge opportunities for growth. This industry will revolutionize the healthcare system and will improve therapeutic effectiveness and reduce the severity of adverse effects. It has enormous potential for investment and the emergence of genetic-based in vitro diagnostics.

Request for sample page:

Table of Contents 

Executive Summary 

  • Objectives of Report
  • Data Sources and Methodology
  • Key Findings and Observations
  • What Makes Cancer Biomarkers so Important for the Healthcare Industry
  • What Technologies are Used to Identify Novel Biomarkers
  • Increase in Cancer Prevalence is Propelling the Oncogenic Biomarker Market
  • Global and US Economic Impact of Cancer
  • How Cancer Biomarkers are Revolutionizing Cancer Treatment
  • What are the most Significant and Strategic Cancer Biomarkers
  • Global Biomarker Test Market Analysis
  • Global Cancer Biomarker Market Analysis
  • Oncology Biomarker Market Main Industry Players
  • Drivers, Restraints, Opportunities and Challenges of the Cancer Biomarker Market

Global Burden of Cancer 

  • Global Cancer Statistics
  • Lung Cancer Globally
  • Lung Cancer Mutation Analysis
  • Colorectal (Bowel) Cancer Globally
  • Prostate Cancer Globally
  • Breast Cancer Globally
  • Global Economic Impact of Cancer
  • Cancer in the USA
  • Breast Cancer in the US
  • Lung Cancer in the US
  • Colorectal Cancer in the US
  • Prostate Cancer in the US
  • Skin Cancer in the US

Oncogenic Biomarkers - An Overview 

  • Biomarker Discovery to Clinical Validation
  • Specific Technologies Used in Biomarker Discovery
  • Proteomics
  • Mass Spectrometry Based Technologies
  • Principles of Diagnostic Mass Spectrometry
  • Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
  • Nano LC-MS/MS
  • Glycomics
  • Metabolomics
  • Peptidomics
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Selected (Multiple) Reaction Monitoring
  • DNA Based Techniques
  • Microarrays
  • Small Molecule Real Time (SMRT) DNA Sequencing
  • Digital PCR
  • Next Generation Sequencing
  • Second-Generation Sequencing Platforms
  • Whole Genome Sequencing
  • Epigenomics
  • Bioinformatics and Next Generation Sequencing
  • Third Generation Sequencing

Biomarker Validation 

  • Introduction
  • Phases of Biomarker Validation
  • Biomarker Validation and Clinical Trials

For more information and complete table of contents: 

Related Reports 

Related Category: 

About Bharat Book Bureau 

Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

Contact us: 


Bharat Book Bureau

USA/Canada - 1-866-279-8368 (Toll free)

India: +91-22-27810772, 27810773




SOURCE Bharat Book Bureau